Ipsen to buy some Merrimack assets for about $1 billion

Jan 8 (Reuters) - French drugmaker Ipsen SA said on

Monday it would buy some assets of U.S. peer Merrimack

Pharmaceuticals Inc, including its pancreatic cancer

treatment Onivyde, for about $1 billion.

Read more